Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital

• Main Authors: Azizah Attard (Author), John Wakelam (Author), Josephine Broyd (Author), David Taylor (Author), Jonathan Hafferty (Author)
• Formato: Livro
• Publicado em: SAGE Publishing, 2022-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Olanzapine pamoate has been shown to be an effective second-generation long-acting injection. Its popularity has possibly been adversely affected by the rare incidence of post-injection syndrome (PIS) and the associated requirement to monitor for 3 h after each injection. Objective: This...